Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...